-
Cancer Cell Hibernation May Explain Mesothelioma Chemotherapy Resistance
Researchers working to find a cure for malignant mesothelioma are consistently frustrated. The disease has proven itself able to withstand nearly every protocol, and is especially resistant to the effects of chemotherapy. A group of scientists from the Princess Margaret Cancer Centre in Toronto have determined that a similar resistance in colon cancer is caused
-
Family’s Mesothelioma Tragedy Extends to Another Sibling
There have been many individual victims of asbestos exposure, ranging from factor workers to baby powder users who have unknowingly breathed in the carcinogenic fibers and later been diagnosed with malignant mesothelioma. But there are few families that have been impacted in the way that the Legendre family has. A recent court filing points to
-
Jury Awards $10 Million to 79-Year-Old After Childhood Asbestos Exposure Led to Mesothelioma
A Washington state jury spent two weeks listening virtually to evidence in a mesothelioma lawsuit filed by a 79-year-old who’d been exposed to asbestos as a toddler. When it was all over, they awarded George Kraemer $10 million in damages, allowing the former assistant principal, middle school science teacher and coach to hold those responsible
-
“Excellent Survival Outcome” Seen from Treating Mesothelioma with Immunotherapy/Chemotherapy Combination
Malignant mesothelioma is a notoriously challenging and aggressive cancer, but researchers are finding that combining new protocols with traditional forms of treatment is yielding significantly improved results. This morning immune-oncology company Targovax ASA announced that by combining their ONCOS-102 immune activator with Standard of Care chemotherapy as a first-line treatment they were able to help
-
Mesothelioma-Stricken Air Force Vet Seeks Compensation from Aircraft Part Companies
Paul Klick III served in the U.S. Air Force for years, and he and his wife Julie blame asbestos-contaminated aircraft parts he was exposed to for his diagnosis with malignant mesothelioma. They are seeking justice from multiple companies, including Boeing and Pneumo Abex, as well as from pharmaceutical companies for his unrelated asbestos exposure from
-
$3.5 Million in Damages Awarded to Illinois Mesothelioma Victim’s Family
Almost seven years after her husband was diagnosed with malignant mesothelioma, a Chicago widow and her adult children heard a jury award them $3.5 million in damages. According to attorneys for Fred Riebel’s estate, BP, U.S. Steel, and others were aware of the dangers of asbestos but did little to protect him from breathing in
-
Appeals Court Upholds $2.2 Million Mesothelioma Verdict Against ExxonMobil
Mesothelioma victims can seek compensation from the companies that negligently exposed them to the asbestos, but suing a major corporation can be intimidating. In Wayne Wright’s case the pursuit of justice was worth the effort. After his father died of the rare asbestos-related disease he sued Exxon, Shell Oil, Texaco Inc., and others, with all
-
Supreme Court Refusal of Second J & J Talc Lawsuit A Win for Mesothelioma and Ovarian Cancer Victims
Thousands of malignant mesothelioma and ovarian cancer victims have accused Johnson & Johnson of knowingly exposing them to asbestos in their talc-based baby powder product. In addition to personal injury lawsuits, litigation has been filed against the consumer giant by Mississippi’s state consumer agency for not having placed a warning label on the product. When
-
Testimony from Mesothelioma Victim’s Father at Issue in Lawsuit
When Matthew Strong died of peritoneal mesothelioma, his wife filed suit against Honeywell International seeking compensation for herself and for his estate. She claimed that he’d been exposed to asbestos in Bendix-brand automotive brakes that the company manufactured, and to support her claim she entered testimony by Matthew’s father, Terry. When Terry died a year
-
Mesothelioma Patients with Fluid in Abdomen See Benefit from Use of Shunt
Patients diagnosed with malignant pleural and peritoneal mesothelioma are both vulnerable to an accumulation of excess fluid that can create significant discomfort. While pleural mesothelioma patients are able to get rid of effusions in their chest through either a catheter or a procedure known as talc pleurodesis, those with peritoneal mesothelioma have traditionally had fewer
-
After Mesothelioma Widow Wins Appeal, Baby Powder Case Can Go to Trial
Before Douglas Strobel died of malignant mesothelioma in 2020, he and his wife Jo Ann were in the midst of a legal battle against Johnson & Johnson. They had charged the company with negligence and fraud, accusing them of having known that the talc in their baby powder product was contaminated with asbestos, which they
-
Cancer Cell Discovery May Boost Impact of Mesothelioma Treatment
Mesothelioma researchers may benefit from a remarkable new discovery about cancer cells. According to a report published in the journal Nature Nanotechnology, scientists from the Brigham and Women’s Hospital have identified a mechanism that helps cancer cells increase the amount of energy they use to grow while at the same time depleting the energy that the immune
-
Can New Drug Stop Mesothelioma’s Spread?
Finding a cure for malignant mesothelioma is an international effort, and a drug being tested by Chinese researchers is among the most promising around. Apatinib, also known as Rivoceranib, stops tumors from generating the blood vessels they need to grow and spread. When the drug was tested as a third-line treatment three years ago it
-
Asbestos Company’s Attempt to Keep Mesothelioma Case in Federal Court Fails
When pursuing a personal injury lawsuit against an asbestos company, mesothelioma victims and their families must make many decisions, including whether to pursue their case in federal court or in a state court. State courts offer several advantages. They are both more convenient for victims who are struggling with their symptoms and medical treatment, and
-
Should Women with Mesothelioma Reconsider Immunotherapy Treatment?
For patients diagnosed with malignant mesothelioma, immunotherapy represents an exciting and promising treatment option. But a new study published in the December 2nd issue of JAMA Network Open is questioning whether women with various types cancer respond differently to the protocol. The study followed male and female advanced melanoma patients treated with the same combination of checkpoint inhibitors.
-
Violators Jailed and Fined After Asbestos Mishandling Raised Community Risk of Mesothelioma
Two asbestos criminals will be jailed and fined $399,000 after being convicted of exposing their workers and the community-at-large to the risk of mesothelioma. Stephanie Laskin and Kristofer Landell were convicted of conspiring to violate Clean Air Act regulations regarding the safe removal, handling, and disposal of the carcinogenic material at a Kingston, New York
-
California Company to Initiate Phase 2 Trial of Mesothelioma Drug
Malignant mesothelioma is among the most challenging cancers to treat. The rare form of cancer, caused by exposure to asbestos, has proven resistant to chemotherapy, and as each new therapeutic has been introduced its tumors have revealed a new defense. In response to the use of checkpoint inhibitors and CAR-T protocols, mesothelioma cells secrete transforming
-
Italian Asbestos Study Shows Risks of Both Mesothelioma and Lung Cancer in Exposed Workers
When discussing the extreme risk of asbestos exposure, malignant mesothelioma gets the lion’s share of attention. But a just-published study by Italian researchers suggests that the rare, terminal disease is only part of the story. In looking at the number of asbestos-exposed workers who died of lung cancer and comparing it to the number of
-
Study Finds Ultrasound Superior to CT for Mesothelioma Biopsy Guidance
Malignant mesothelioma is often suspected when a person with a known exposure to asbestos starts having symptoms. But doctors cannot simply assume that they are right. The first step to meaningful treatment is confirmation of the diagnosis, and this requires collecting a sample of the tumor’s cells for analysis. The collection procedure is known as
-
Jury’s Anger at Negligence Leads to $26.5 Million Mesothelioma Verdict
Juries hearing mesothelioma lawsuits often spend weeks hearing evidence about how the rare form of cancer develops, about asbestos, and how the victim was exposed to the deadly material. They are then asked to determine whether negligence occurred. The process can be contentious, but a Wisconsin jury’s only disagreement was over the amount to be
